Articles Tagged With:
-
High-risk ED Abdominal Cases Involved These Diagnostic Errors
Researchers developed an electronic tool to identify patients who presented to the ED of an urban academic hospital with acute abdominal pain who were discharged home, had a return ED visit within 10 days, and were admitted to the hospital when they returned.
-
Plaintiff Attorney Could Have Tough Time Proving Causation in ED Med/Mal Suit
The plaintiff’s attorney must prove that the EP breached the standard of care, and that the breach caused the alleged damages.
-
Hospital Consult - February 2016
-
ED Push - February 2016 Second Issue
-
FDA Actions
The FDA has approved a new fixed-dose combination oral, once-daily pill to treat hepatitis C genotypes 1 and 4.
-
Time to Limit Proton Pump Inhibitors?
A new study suggests the commonly used drugs may be associated with chronic kidney disease.
-
Promising Treatment Not Widely Available
Among adults with recurrent or refractory Clostridium difficile infection, the use of frozen compared with fresh fecal microbiota transplantation did not result in worse proportion of clinical resolution of diarrhea.
-
New Recommendations for Bisphosphonate Therapy
For women who are not at high risk after 3-5 years of bisphosphonate therapy, a drug holiday of 2-3 years may be considered.
-
Study: No Link Between Dementia, Benzodiazepine Use
New research upends previous beliefs.
-
Updated Antithrombotic Therapy Guidelines Released
The guideline contains some significant changes from the previous CHEST guidelines.